INS and diabetes mellitus: Sphingolipids modulate several beta-cell signaling pathways involved in the progression of diabetes such as apoptosis, cytokine secretion, ER to golgi trafficking, islet autoimmunity and insulin gene expression and furthermore, sphingolipid metabolism on internal membranes is also implicated in the regulation of beta-cell apoptosis.